Authors: Kesmarky, G Toth, K Vajda, G Habon, L Halmosi, R Roth, E

Citation: G. Kesmarky et al., Hemorheological and oxygen free radical associated alterations during and after percutaneous transluminal coronary angioplasty, CL HEMORH M, 24(1), 2001, pp. 33-41

Authors: Marton, Z Halmosi, R Horvath, B Alexy, T Kesmarky, G Vekasi, J Battyany, I Hideg, K Toth, K

Citation: Z. Marton et al., Scavenger effect of experimental and clinically used cardiovascular drugs, J CARDIO PH, 38(5), 2001, pp. 745-753

Authors: Halmosi, R Berente, Z Osz, E Toth, K Literati-Nagy, P Sumegi, B

Citation: R. Halmosi et al., Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system, MOLEC PHARM, 59(6), 2001, pp. 1497-1505

Authors: Habon, T Szabados, E Kesmarky, G Halmosi, R Past, T Sumegi, B Toth, K

Citation: T. Habon et al., The effect of carvedilol on enhanced ADP-ribosylation and red blood cell membrane damage caused by free radicals, CARDIO RES, 52(1), 2001, pp. 153-160

Authors: Toth, K Kesmarky, G Vekasi, J Nemes, J Czopf, L Kapronczay, P Halmosi, R Papp, E Juricskay, I

Citation: K. Toth et al., Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment, CL HEMORH M, 21(3-4), 1999, pp. 209-216

Authors: Czopf, L Halmosi, R Kesmarky, G Habon, T Toth, K Juricskay, I Roth, E Mozsik, G

Citation: L. Czopf et al., Lovastatin and nitrate therapy induced changes in hemorheological parameters and in free radical mediated processes in patients with ischemic heart disease, PERFUSION, 12(2), 1999, pp. 50